Ignite Creation Date:
2024-05-05 @ 12:10 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00262275
Status:
COMPLETED
Last Update Posted:
2016-01-22
First Post:
2005-12-05
Brief Title:
Optimum Platelet Inhibition After Coronary Bypass Surgery
Sponsor:
Papworth Hospital NHS Foundation Trust
Organization:
Papworth Hospital NHS Foundation Trust
Study Overview
Official Title:
Optimum Platelet Inhibition After Coronary Artery Bypass Surgery A Randomised Trial Comparing Platelet Aggregation Using Low Medium Dose Aspirin and Clopidogrel
Status:
COMPLETED
Status Verified Date:
2016-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To investigate the effect of different dosages of aspirin on platelet aggregation and to determine the possible mechanisms of aspirin resistance we intend to compare the effects of low medium dose aspirin with clopidogrel an alternative antiplatelet agent in patients after coronary artery bypass surgery
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None